Amgen | AMGN - Ebitda





Ebitda Alterar Data
AbbVie USD 3.69B 1.68B 2026-03
Agios Pharmaceuticals USD -108.66M 11.65M 2026-03
ALKERMES USD 139.22M 58.96M 2026-06
Amgen USD 3.86B 1.28B 2026-03
Biogen USD 450.8M 198.9M 2026-06
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Bristol-Myers Squibb USD 5.09B 842M 2026-06
Coherus Biosciences USD -43.33M 4.7M 2025-09
Eli Lilly USD 12.99B 2.7B 2026-06
Exelixis USD 255.4M 2.89M 2026-06
Genmab DKK 401M 186M 2026-06
Gilead Sciences USD -9.31B 12.82B 2026-06
GlaxoSmithKline GBP 3.51B 734M 2026-06
Glaxosmithkline GBP 2.77B 1.98B 2026-03
Incyte USD 778.57M 410.6M 2026-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
J&J USD 8.99B 721M 2026-06
Merck USD 1.42B 2.97B 2026-06
Moderna USD -1.26B 468M 2026-03
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Novartis USD 8.62B 2.14B 2026-09
Novartis USD 5.41B 431M 2026-03
Pfizer USD 6.01B 18M 2026-06
PTC Therapeutics USD 161.9M 99.92M 2026-06
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 3.69B 375M 2026-06
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
Takeda JPY 369.75B 5.29B 2026-09
Teva Pharmaceutical Industries USD 474M 581M 2026-06
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06